By G HossainPosted on June 18, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABAA modulators are poised for clinical trials in 2026. Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs Post navigation In the blogs: Breathing roomMore Than One-Third of Biotechs Have Under a Year of Cash Left, EY Finds